Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-24 @ 11:49 PM
NCT ID:
NCT01513551
Eligibility Criteria:
Inclusion Criteria:
-Without fever for 72 hours prior to vaccination
Exclusion Criteria:
* Prior receipt of any pneumococcal polysaccharide vaccine or any pneumococcal conjugate vaccine
* Known or suspected to be immunocompromised
* Functional or anatomic asplenia
* History of autoimmune disease
* Evidence of dementia or cognitive impairment
* Use of any immunosuppressive therapy
* Received a licensed non-live vaccine administered within the 14 days prior to receipt of study vaccine or scheduled to receive any other licensed vaccine within 30 days following receipt of study vaccine
* Received a licensed live virus vaccine within 30 days prior of receipt of study vaccine or is scheduled to receive any other licensed vaccine within 30 days of receipt of study vaccine
* Received any vaccine containing diphtheria toxoid within 6 months prior to receipt of study vaccine
* Received a blood transfusion or blood products within the 6 months before receipt of study vaccine or scheduled to receive a blood transfusion or blood product within 30 days of receipt of study vaccine
* History of invasive pneumococcal disease or known history of other culture-positive pneumococcal disease
* Received antibiotic therapy for any acute illness within 72 hours before receipt of study vaccine
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT01513551
Study Brief:
Protocol Section:
NCT01513551